Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Video Laringeal Mask vs. Endotraqueal Tube en septoplastia

12 de noviembre de 2026 actualizado por: Samsun University

Comparación de videos de la vía aérea laríngea y el uso de tubos endotraqueales para la seguridad de las vías respiratorias en pacientes sometidos a septoplastia

This study compares two devices used to help adults breathe during general anesthesia for septoplasty, an operation to straighten the wall between the two sides of the nose. The study is conducted at one hospital and includes adults aged 18-65 years.

The main question is whether the amount of blood found in the airway at the end of surgery differs between the two devices. Researchers also compare breathing measurements, heart rate and blood pressure, device placement, recovery from anesthesia, surgeon satisfaction, and throat symptoms after surgery.

Participants receive either a SaCoVLM™ video laryngeal mask, which sits above the opening of the windpipe and has a built-in camera, or a conventional breathing tube placed inside the windpipe. The devices are assigned in a fixed alternating order, rather than by chance.

At the end of surgery, researchers check for blood inside the windpipe using a thin, flexible camera in both groups. They also assess blood near the opening of the windpipe using methods specific to each device.

Sore throat, difficulty swallowing, cough, and hoarseness are assessed in the recovery unit and at 2, 8, 12, 24, and 48 hours after surgery.

Descripción general del estudio

Descripción detallada

This single-center, prospective, non-randomized, interventional study compares the SaCoVLM™ video laryngeal mask airway (VLMA) with a conventional endotracheal tube (ETT) in adults aged 18-65 years with American Society of Anesthesiologists (ASA) physical status I-II undergoing elective septoplasty under general anesthesia.

Consecutive eligible patients are assigned to the ETT and VLMA groups in a predetermined alternating sequence. Allocation is systematic rather than random, and no random sequence generator is used.

Anesthetic Management

Standard monitoring includes electrocardiography, noninvasive blood pressure, peripheral oxygen saturation, end-tidal carbon dioxide, and bispectral index monitoring. Anesthesia is induced with intravenous fentanyl and propofol and maintained with sevoflurane and remifentanil.

Volume-controlled ventilation is delivered with a tidal volume of 6-8 mL/kg, a respiratory rate of 12 breaths/min, a positive end-expiratory pressure of 5 cmH2O, and an inspiratory-to-expiratory ratio of 1:2.

Hemodynamic and respiratory measurements are obtained, as applicable, at baseline, after anesthesia induction immediately before airway device placement, at 1, 3, 5, 10, 15, and 30 minutes after placement, and 5 minutes after device removal.

Airway Blood Contamination

The primary outcome is airway blood contamination at the end of surgery, graded on a four-point scale: 1 = no blood, 2 = mild contamination, 3 = moderate contamination, and 4 = severe contamination.

In the VLMA group, proximal glottic blood contamination is assessed directly through the device's integrated camera. In the ETT group, proximal contamination is assessed indirectly by inspecting blood around the tube cuff after careful aspiration of the posterior oropharynx and extubation. These assessments are device-specific and do not represent anatomically equivalent measurements.

Distal tracheal blood contamination is assessed by flexible bronchoscopy in both groups, regardless of the proximal findings.

Additional Assessments

Secondary outcomes include hemodynamic responses, ventilation parameters, airway device insertion time, number of placement attempts, ease of placement, ventilation leakage, peak airway pressure, glottic visualization, surgeon satisfaction, and early postoperative recovery.

Recovery is assessed using recovery time and the Modified Aldrete Score. Postoperative sore throat, dysphagia, cough, and hoarseness are assessed in the post-anesthesia care unit and at 2, 8, 12, 24, and 48 hours after surgery.

Tipo de estudio

Intervencionista

Inscripción (Actual)

70

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Ilkadim
      • Samsun, Ilkadim, Turquía (Türkiye), 55000
        • Samsun University, Samsun Training and Research Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 65 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Patients aged 18-65 years
  • ASA physical status I-II
  • Patients scheduled for elective septoplasty under general anesthesia

Exclusion Criteria:

  • Anticipated difficult airway
  • ASA physical status III-IV
  • History of gastroesophageal reflux disease or hiatal hernia
  • Body mass index greater than 30 kg/m²
  • Pregnancy

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: No aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: VLMA Group

Thirty-five patients were allocated to airway management using the SaCoVLM™ video laryngeal mask airway (VLMA) according to a predetermined alternating allocation sequence. Three patients experienced ventilation-related difficulties and were excluded from the final comparative analysis. The remaining 32 patients were analyzed. Proximal glottic blood contamination was assessed using the integrated camera, and distal tracheal blood contamination was evaluated using flexible bronchoscopy in all 32 analyzed patients.

The SaCoVLM™ video laryngeal mask airway, a supraglottic airway device with an integrated camera, was used for airway management during elective septoplasty. The integrated camera enabled direct visualization of the glottic inlet and assessment of proximal blood contamination. At the end of surgery, distal tracheal blood contamination was assessed using flexible bronchoscopy in all 32 VLMA patients included in the final analysis, regardless of proximal blood contamination findings. Airway insertion characteristics, ventilation and hemodynamic parameters, recovery outcomes, and postoperative airway morbidity were recorded.

Comparador activo: ETT Group

Thirty-five patients were allocated to airway management using a conventional cuffed endotracheal tube (ETT) according to a predetermined alternating allocation sequence. Three patients were excluded from the final comparative analysis because surgical duration exceeded 90 minutes. The remaining 32 patients were analyzed. Proximal blood contamination was assessed by examining blood around the ETT cuff after oropharyngeal aspiration and extubation. Distal tracheal blood contamination was evaluated using flexible bronchoscopy in all 32 analyzed patients.

A conventional cuffed endotracheal tube was inserted using direct laryngoscopy for airway management during elective septoplasty. At the end of surgery, the distal trachea was examined for blood contamination using flexible bronchoscopy through the ETT before removal. Proximal tracheal/glottic contamination was assessed indirectly by examining blood around the distal portion of the ETT cuff after aspiration of the posterior oropharynx and extubation. Airway insertion characteristics, ventilation and hemodynamic parameters, recovery outcomes, and postoperative airway morbidity were recorded.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Airway Blood Contamination at the End of Surgery
Periodo de tiempo: At the end of surgery, immediately before and/or after airway device removal, depending on the assessment method.

Airway blood contamination was assessed at the end of surgery at two anatomical levels: proximal glottic/tracheal and distal tracheal regions.

Contamination was graded using a four-point ordinal scale: 1 = no blood, 2 = mild contamination, 3 = moderate contamination, and 4 = severe contamination. Higher scores indicated greater blood contamination.

In the VLMA group, proximal glottic blood contamination was assessed directly using the integrated camera. In the ETT group, proximal blood contamination was assessed indirectly by examining blood around the endotracheal tube cuff following oropharyngeal aspiration and extubation. These assessment methods were device-specific and anatomically non-equivalent.

Distal tracheal blood contamination was assessed using flexible bronchoscopy in all 64 patients included in the final analysis (32 patients per group), regardless of proximal contamination findings.

Contamination scores were recorded separately for the proximal and distal regions. N

At the end of surgery, immediately before and/or after airway device removal, depending on the assessment method.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Heart Rate (HR)
Periodo de tiempo: From preoperative baseline to 5 minutes after airway device removal.

Heart rate, measured in beats per minute, was recorded at preoperative baseline; after anesthesia induction immediately before airway device placement; at 1, 3, 5, 10, 15, and 30 minutes after successful airway device placement; and at 5 minutes after airway device removal.

From preoperative baseline to 5 minutes after airway device removal.
Postoperative Sore Throat (POST Score)
Periodo de tiempo: From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).

Postoperative sore throat was assessed by direct patient questioning using a four-point ordinal scale: 0 = no sore throat; 1 = cold-like sensation or minimal discomfort; 2 = mild-to-moderate pain during swallowing; and 3 = continuous pain without swallowing.

Assessments were scheduled during post-anesthesia care unit recovery and at 2, 8, 12, 24, and 48 hours postoperatively. Between-group comparative analyses were performed through 12 hours. Findings at 24 and 48 hours were summarized descriptively using available symptom scores. Discharge entries and blank symptom scores were considered missing data. Missing scores were not imputed.

From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).
Arterial Blood Pressure
Periodo de tiempo: From preoperative baseline to 5 minutes after airway device removal.

Systolic, diastolic, and mean arterial blood pressures, measured in mmHg, were recorded at preoperative baseline; after anesthesia induction immediately before airway device placement; at 1, 3, 5, 10, 15, and 30 minutes after successful airway device placement; and at 5 minutes after airway device removal.

From preoperative baseline to 5 minutes after airway device removal.
Airway Insertion Time
Periodo de tiempo: Assessed once during airway device placement, immediately after anesthesia induction.

Airway insertion time was recorded in seconds. In the ETT group, it was defined as the time from the start of the intubation attempt until three consecutive regular end-tidal carbon dioxide waveforms were observed on capnography. In the VLMA group, it was defined as the time from picking up the device until three consecutive regular end-tidal carbon dioxide waveforms were observed on capnography.

Assessed once during airway device placement, immediately after anesthesia induction.
Intraoperative and Early Postoperative Airway Complications
Periodo de tiempo: From anesthesia induction through the early postoperative period in the post-anesthesia care unit.

The occurrence of laryngospasm and bronchospasm was assessed through clinical observation during the intraoperative and early postoperative periods. Each complication was recorded separately as present or absent.

From anesthesia induction through the early postoperative period in the post-anesthesia care unit.
Postoperative Dysphagia
Periodo de tiempo: From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).

Postoperative dysphagia was assessed by direct patient questioning using a four-point ordinal scale: 0 = no swallowing difficulty; 1 = minimal discomfort during swallowing; 2 = mild-to-moderate difficulty during swallowing; and 3 = marked swallowing difficulty.

Assessments were scheduled during post-anesthesia care unit (PACU) recovery and at 2, 8, 12, 24, and 48 hours postoperatively. Between-group comparative analyses were restricted to assessments through 12 hours. Findings at 24 and 48 hours were summarized descriptively using available symptom scores. Discharge entries and blank symptom scores were classified as missing data. Missing scores were not imputed.

From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).
First-Attempt Success Rate of Airway Device Insertion
Periodo de tiempo: Assessed once during airway device placement immediately after anesthesia induction.

First-attempt success was recorded separately for each airway device as successful or unsuccessful. The total number of placement attempts required to achieve successful airway placement was also recorded. Successful placement was confirmed by three consecutive regular end-tidal carbon dioxide waveforms.

Assessed once during airway device placement immediately after anesthesia induction.
Postoperative Cough
Periodo de tiempo: From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).

Postoperative cough was assessed using a four-point ordinal scale: 0 = no cough; 1 = mild cough; 2 = moderate cough; and 3 = severe cough.

For statistical analysis, cough scores were categorized as absent (score 0) or present (scores 1-3). Results were expressed as the number and percentage of patients with cough in each group.

Assessments were scheduled during post-anesthesia care unit (PACU) recovery and at 2, 8, 12, 24, and 48 hours postoperatively. Between-group comparative analyses were restricted to assessments through 12 hours. Findings at 24 and 48 hours were summarized descriptively using available symptom scores. Discharge entries and blank symptom scores were classified as missing data. Missing scores were not imputed.

From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).
Postoperative Hoarseness
Periodo de tiempo: From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).

Postoperative hoarseness was assessed using a four-point scale: 0 = no hoarseness; 1 = mild voice changes; 2 = moderate voice changes; and 3 = marked hoarseness.

For statistical analysis, scores were categorized as absent (0) or present (1-3). Results were expressed as the number and percentage of patients with hoarseness in each group.

Assessments were scheduled during post-anesthesia care unit (PACU) recovery and at 2, 8, 12, 24, and 48 hours postoperatively. Between-group comparative analyses were restricted to assessments through 12 hours. Findings at 24 and 48 hours were summarized descriptively using available symptom scores. Discharge entries and blank symptom scores were classified as missing data. Missing scores were not imputed.

From PACU recovery through 48 hours postoperatively (PACU, 2, 8, 12, 24, and 48 hours).
Surgeon Satisfaction With Surgical Conditions
Periodo de tiempo: At the end of surgery (single assessment).

Surgeon satisfaction with surgical conditions was assessed at the end of surgery using a four-point ordinal scale: 0 = very good, 1 = good, 2 = poor, and 3 = very poor (surgical conditions unsuitable for initiating the procedure). Lower scores indicated greater satisfaction. Results were expressed as the number and percentage of patients in each category for both groups.

At the end of surgery (single assessment).

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Director de estudio: Hatice Selcuk KUSDERCI, M.D., Samsun University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

30 de abril de 2025

Finalización primaria (Actual)

3 de noviembre de 2025

Finalización del estudio (Actual)

4 de noviembre de 2025

Fechas de registro del estudio

Enviado por primera vez

24 de marzo de 2025

Primero enviado que cumplió con los criterios de control de calidad

27 de abril de 2025

Publicado por primera vez (Actual)

30 de abril de 2025

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

18 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir